Search clinical trials for: AZD0585 placebo
Total 53517 results
-
AstraZenecaCompleted
-
AstraZenecaCompletedHealthy ParticipantsUnited States
-
AstraZenecaCompletedIdiopathic Pulmonary FibrosisUnited States
-
AstraZenecaAstraZeneca K.K.RecruitingDyslipidemiaDenmark, Hungary, Spain, United States, Japan, Czechia, Slovakia, Canada
-
AstraZenecaTerminatedPlaque Psoriasis VulgarisDenmark
-
AstraZenecaQuotient SciencesCompleted
-
AstraZenecaParexelCompletedPlaque Psoriasis VulgarisUnited Kingdom
-
Yale UniversityCompleted
-
AstraZenecaRecruitingB-cell Acute Lymphoblastic Leukemia (B-ALL)Spain, Canada, United Kingdom, Italy, Germany, Australia, United States, Taiwan, France, Korea, Republic of, China
-
AstraZenecaCompletedNon-Small Cell Lung Cancer | Advanced Solid TumoursUnited States, United Kingdom
-
AstraZenecaCompleted
-
AstraZenecaParexelTerminatedType 2 DiabetesUnited States
-
Yale UniversityAlzheimer's Therapeutic Research InstituteCompletedAlzheimer's DiseaseUnited States, Canada
-
AstraZenecaNot yet recruitingHepatocellular Carcinoma | Prostate CancerUnited States
-
AstraZenecaRecruitingMultiple MyelomaUnited States, Spain, Australia, Canada, Germany, China, Japan
-
AstraZenecaCompletedGERD Without Erosive EsophagitisSweden, United States, France, Italy, United Kingdom, Germany, Denmark, Finland, Norway, Canada
-
AstraZenecaCompletedSolid TumorsUnited States, France, United Kingdom
-
AstraZenecaCompletedGERD With Erosive EsophagitisSweden, United States, France, Italy, United Kingdom, Germany, Denmark, Finland, Norway, Canada
-
Stephen M. StrittmatterNational Institute of Neurological Disorders and Stroke (NINDS)CompletedAlzheimer's DiseaseUnited States
-
AstraZenecaParexelCompleted
-
AstraZenecaCompletedCancer | Solid Tumors | Advanced Solid MalignanciesJapan
-
AstraZenecaWithdrawnCancer | Advanced Solid Tumours | Lymphomas
-
Amsterdam UMC, location VUmcAstraZeneca; Brigham and Women's Hospital; University of Oxford; Klinikum Garmisch-Patenkirchen and other collaboratorsRecruitingFibrodysplasia Ossificans ProgressivaGermany, Netherlands, United Kingdom
-
AstraZenecaRecruitingA Phase I/II Study to Evaluate AZD5851 in GPC3+ Advanced/Recurrent Hepatocellular Carcinoma (ATHENA)Hepatocellular CarcinomaUnited States, Korea, Republic of
-
National Cancer Institute (NCI)CompletedGlioblastoma Multiforme | Malignant Glioma | Anaplastic Astrocytoma | Anaplastic Oligodendroglioma | Brainstem GliomaUnited States
-
AstraZenecaRecruitingFollicular Lymphoma | Diffuse Large B Cell Lymphoma | High-grade B-cell Lymphoma | B-cell Non Hodgkin LymphomaKorea, Republic of, United States, Japan, Australia, Taiwan
-
AstraZenecaCompletedCancer | Advanced Hepatocellular CarcinomaKorea, Republic of, Hong Kong
-
National Cancer Institute (NCI)TerminatedRecurrent Prostate Cancer | Hormone-resistant Prostate Cancer | Stage IV Prostate CancerUnited States
-
Yale UniversityNational Institute on Alcohol Abuse and Alcoholism (NIAAA)Completed
-
National Cancer Institute (NCI)CompletedRecurrent Melanoma | Stage IV Melanoma | Stage IIB Melanoma | Stage IIC Melanoma | Stage IIA MelanomaUnited States
-
AstraZenecaCompleted
-
AstraZenecaParexelRecruitingDyslipidemiaUnited States, United Kingdom
-
Baylor College of MedicineUniversity of South Florida; National Institutes of Health (NIH); Brigham and... and other collaboratorsTerminatedPulmonary LymphangioleiomyomatosisUnited States
-
AstraZenecaCompleted
-
AstraZenecaParexelTerminatedHealthy SubjectsUnited Kingdom
-
National Cancer Institute (NCI)CompletedUterine Carcinosarcoma | Endometrial Stromal Sarcoma | Recurrent Adult Soft Tissue Sarcoma | Recurrent Uterine Sarcoma | Stage III Adult Soft Tissue Sarcoma | Stage III Uterine Sarcoma | Stage IV Adult Soft Tissue Sarcoma | Stage IV Uterine Sarcoma | Dermatofibrosarcoma Protuberans | Adult Rhabdomyosarcoma and other conditionsCanada, United States
-
National Cancer Institute (NCI)TerminatedInvasive Thymoma and Thymic Carcinoma | Recurrent Thymoma and Thymic Carcinoma | Stage III Thymoma | Stage IVA Thymoma | Stage IVB ThymomaUnited States
-
National Cancer Institute (NCI)CompletedAdenocarcinoma of the Gastroesophageal Junction | Stage IV Gastric Cancer | Recurrent Gastric Cancer | Stage III Gastric Cancer | Adenocarcinoma of the Stomach | Stage IV Esophageal Cancer | Stage III Esophageal CancerCanada, United States
-
National Cancer Institute (NCI)CompletedLung Metastases | Extensive Stage Small Cell Lung Cancer | Recurrent Small Cell Lung Cancer | Malignant Pleural EffusionUnited States
-
National Cancer Institute (NCI)CompletedStage IIIB Non-small Cell Lung Cancer | Recurrent Non-small Cell Lung Cancer | Stage IV Non-small Cell Lung CancerCanada
-
Tony EissaUniversity of Texas; University of CincinnatiCompletedPulmonary LymphangioleiomyomatosisUnited States
-
National Cancer Institute (NCI)CompletedTongue Cancer | Recurrent Metastatic Squamous Neck Cancer With Occult Primary | Recurrent Squamous Cell Carcinoma of the Hypopharynx | Recurrent Squamous Cell Carcinoma of the Larynx | Recurrent Squamous Cell Carcinoma of the Lip and Oral Cavity | Recurrent Squamous Cell Carcinoma of the Oropharynx and other conditionsUnited States
-
AstraZenecaCompleted
-
Yale UniversityNational Institute on Alcohol Abuse and Alcoholism (NIAAA)CompletedAlcohol DrinkingUnited States
-
National Cancer Institute (NCI)TerminatedStage IV Colon Cancer | Stage IV Rectal Cancer | Recurrent Colon Cancer | Recurrent Rectal Cancer | Adenocarcinoma of the Rectum | Adenocarcinoma of the ColonUnited States
-
National Cancer Institute (NCI)CompletedRecurrent Prostate Cancer | Hormone-resistant Prostate CancerUnited States
-
National Cancer Institute (NCI)CompletedMale Breast Cancer | Stage IV Breast Cancer | Stage IIIB Breast Cancer | Stage IIIC Breast Cancer | Recurrent Breast Cancer | Estrogen Receptor-negative Breast Cancer | Progesterone Receptor-negative Breast CancerUnited States